The bill creates a centralized board to strengthen coordination and transparency in life‑science research security, improving public health protections, but it also imposes disclosure burdens that could deter experts and adds modest costs for taxpayers.
Scientists, researchers, and the public gain a dedicated federal board to coordinate life sciences research security, improving coordination of biosecurity policy and helping protect public health.
Scientists, researchers and taxpayers get greater transparency and oversight because board members must file financial disclosures, reducing risk of undisclosed conflicts of interest.
Scientists, researchers, and federal employees may be deterred from serving on the board because financial disclosure requirements raise privacy concerns and administrative burdens, shrinking the pool of qualified experts.
Taxpayers may face modestly higher administrative costs to staff and operate the new board (salaries, operations, compliance).
Based on analysis of 2 sections of legislative text.
Creates a federal Life Sciences Research Security Board in Title 31 and requires its members to file federal financial disclosure reports.
Introduced March 5, 2025 by H. Morgan Griffith · Last progress March 5, 2025
Creates a new federal Life Sciences Research Security Board in Title 31, U.S. Code and requires members of that Board to file federal financial disclosure reports. It also updates the subtitle chapter table to add the new board and adds a cross-reference in the ethics-disclosure statute to include Board members among officials required to report financial interests. Does not specify funding or operational details beyond establishing the Board and the disclosure requirement; the text adds a new chapter to Subtitle V and amends the financial disclosure provision in 5 U.S.C. to require filings by Board members.